Abstract
By application of morphological and ultrastructural methods for identification of apoptosis, we analyzed the incidence of morphologically evident apoptosis in the bone marrow of 30 patients with myelodysplastic syndrome (MDS), and in the bone marrow of 12 healthy individuals. According to FAB classification, out of 30 patients, eight (26.6%) had refractory anemia, three (10%) had refractory anemia with ringed sideroblasts, 14 (46.6%) had refractory anemia with excess of blasts and two (6.8%) had refractory anemia with excess of blasts in transformation. Three patients (10%) had chronic myelomonocytic leukemia. Cells in apoptosis were examined on semithin slides and expressed as the apoptotic index (AI) (percent counted on at least 1000 cells). An overall increase in apoptosis in patients with MDS was found (median AI in patients vs controls, 3.13% vs 1.05%, P < 0.01 by mann–whitney U test). Also, negative correlation between AI and white blood cell count was found (linear r = −0.53, or Spearman rank R = −0.52, both P < 0.01). in patients with evident karyotype changes ai was not higher than in patients with normal karyotype. this suggests that discrete alterations in apoptosis are present even in karyotypically ‘normal’ clones. our results strongly support the hypothesis that apoptosis has a role in ineffective hematopoiesis and may be a mechanism responsible for the paradox of hypercellular bone marrow and peripheral blood pancytopenia in mds.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bogdanović, A., Trpinac, D., Janković, G. et al. Incidence and role of apoptosis in myelodysplastic syndrome: morphological and ultrastructural assessment. Leukemia 11, 656–659 (1997). https://doi.org/10.1038/sj.leu.2400640
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400640
Keywords
This article is cited by
-
Thrombocytopenia in MDS: epidemiology, mechanisms, clinical consequences and novel therapeutic strategies
Leukemia (2016)
-
Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients
Leukemia (2016)
-
Methylation of the p73 gene in patients with myelodysplastic syndromes: correlations with apoptosis and prognosis
Tumor Biology (2013)
-
Megakaryocytic dysfunction in myelodysplastic syndromes and idiopathic thrombocytopenic purpura is in part due to different forms of cell death
Leukemia (2006)
-
Expression of FLIPLong and FLIPShort in bone marrow mononuclear and CD34+ cells in patients with myelodysplastic syndrome: correlation with apoptosis
Leukemia (2003)